This website uses cookies

The University of Liège wishes to use cookies or trackers to store and access your personal data, to perform audience measurement. Some cookies are necessary for the website to function. Cookie policy.

Profil

Hull David

Département de droit

See author's contact details
Main Referenced Co-authors
Clancy, Michael J. (2)
Gordley, Catherine (1)
Main Referenced Keywords
EU competition law (9); Article 102 (3); drug pricing (3); patent settlements (3); AstraZeneca Judgement (1);
Main Referenced Disciplines
Economic & commercial law (20)
European & international law (20)

Publications (total 20)

The most downloaded
3058 downloads
Hull, D., & Gordley, C. (2018). Gun Jumping in Europe: An Overview of EU and National Case Law. e-Competitions. https://hdl.handle.net/2268/235450

The most cited

10 citations (OpenAlex)

Hull, D., & Clancy, M. J. (2016). Application of EU Competition Law in the Pharmaceutical Sector. Journal of European Competition Law and Practice, 7, 153-161. doi:10.1093/jeclap/lpv093 https://hdl.handle.net/2268/235451

Hull, D. (2019). Droits européen et américain de la concurrence : hipsters contre bobo ? Revue de la Faculté de Droit de l'Université de Liège.
Peer reviewed

Hull, D. (04 December 2018). Biologics & Biosimilars [Paper presentation]. Competition Law Challenges.

Hull, D. (14 November 2018). Competition Law Strategies: - Protect Your Brand - - Protect Your Retail Partners - - Protect Your Revenue - [Paper presentation]. Luxury Law New York Summit.

Hull, D. (12 September 2018). Excessive Pricing in the Pharmaceutical Sector: Recent European Cases [Paper presentation]. European Pharma Law Academy.

Hull, D., & Clancy, M. J. (2018). The Application of EU Competition Law in the Pharmaceutical Sector. Journal of European Competition Law and Practice, 389-402. doi:10.1093/jeclap/lpy035
Peer Reviewed verified by ORBi

Hull, D. (2018). Coty, Asics and Google Shopping: Practical Implications for Distribution Strategy.

Hull, D., & Gordley, C. (2018). Gun Jumping in Europe: An Overview of EU and National Case Law. e-Competitions.
Peer reviewed

Hull, D. (05 December 2017). Excessive Pricing in the Pharmaceuticals Sector [Paper presentation]. Competition Law in the Pharma Sector 2017.

Hull, D. (2017). The Intel Judgment:  Practical Implications for Pricing Strategies.

Hull, D. (13 September 2017). European Competition Law: Recent Developments in the Pharma Sector [Paper presentation]. European Pharma Law Academy.

Hull, D. (16 May 2017). Abuse of Dominance in the Pharmaceuticals Sector: Excessive Pricing, Rebates and Discounts [Paper presentation]. EU Pharmaceutical Law Forum 2017 Brussels.

Hull, D. (February 2017). Application of EU Competition Law in the Pharmaceutical Sector. Journal of European Competition Law and Practice, 3, 205-2018. doi:10.1093/jeclap/lpx004
Peer Reviewed verified by ORBi

Hull, D. (06 December 2016). Patent Settlements under EU Competition Law [Paper presentation]. Competition Law in the Pharma Sector.

Hull, D. (24 May 2016). Abuse of Dominance in the Pharmaceuticals Sector [Paper presentation]. Informa’s 25th Annual EU Pharmaceutical Forum.

Hull, D. (2016). Lundbeck BSC Morning Briefing.

Hull, D. (2016). Patent settlements - The Knowledge Group.

Hull, D., & Clancy, M. J. (2016). Application of EU Competition Law in the Pharmaceutical Sector. Journal of European Competition Law and Practice, 7, 153-161. doi:10.1093/jeclap/lpv093
Peer Reviewed verified by ORBi

Hull, D. (19 May 2015). Competition Cases on Product Denigration: What Can You Say About Competing Products? [Paper presentation]. EU Pharmaceutical Law Forum.

Hull, D. (2010). The AstraZeneca Judgment: Implications for IP and Regulatory Strategies. Journal of European Competition Law and Practice. doi:10.1093/jeclap/lpq057
Peer Reviewed verified by ORBi

Hull, D. (2006). Tying - A transatlantic Perspective. In P. Marsden (Ed.), Handbook of Research in Trans-Atlantic Antitrust (pp. 287-318). Edward Elgar.
Peer reviewed

Contact ORBi